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Abstract
We present computationally simple association tests based on haplotype sharing that can be easily
applied to genome-wide association studies, while allowing use of fast (but not likelihood-based)
haplotyping algorithms, and properly accounting for the uncertainty introduced by using inferred
haplotypes. We also give haplotype sharing analyses that adjust for population stratification. We
apply our methods to a genome-wide association study of rheumatoid arthritis available as Problem
1 of Genetic Analysis Workshop 16. In addition to the HLA region on chromosome 6, we find
genome-wide significant signals at 7q33 and 13q31.3. These regions contain genes with interesting
potential connections with rheumatoid arthritis and are not identified using single single-nucleotide
polymorphism methods.
Background
The large number of markers tested in a genome-wide
association study (GWAS) has forced a simplification of
analytic approaches. While sophisticated methodology
may be used to adjust for multiple comparisons and
population stratification, the sheer number of tests in a
GWAS requires that each test be fairly simple; currently,
most studies are analyzed by computing a simple test
such as the Cochran-Armitage trend test at each locus.
Methods that account for the special features of genetic
association studies, yet remain computationally feasible
for genome-wide analysis, are desirable because they
may lead to increased power to detect associations.
Haplotype sharing is a simple concept that attempts to
translate between population genetics and genetic
epidemiology. In brief, for recent mutations that cause
disease, we would expect that haplotypes of case
participants would be more similar to each other in
the immediate region of a mutation than they would be
to the haplotypes of control participants, suggesting a
comparison of sharing in a region between cases and
controls. We have recently proposed a class of compu-
tationally simple association tests based on haplotype
sharing that can be easily applied to case-control studies
on the genome-wide scale. The computational simplicity
allows for quick assessment of genome-wide significance
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Open Accesswhile adjusting for population stratification via a
stratified analysis employing the two-step method of
Epstein et al. [1]. We apply this methodology to the
rheumatoid arthritis (RA) whole-genome association
data available as Problem 1 of Genetic Analysis Work-
shop 16.
Methods
W eb e g i nb yg i v i n ga no v e r v i e wo ft h ec l a s so ft e s t
statistics we consider. A more detailed presentation of
our approach can be found in Allen and Satten [2]. Let di
and zi indicate disease status and stratum membership,
respectively, for the i
th individual. We consider haplo-
types of fixed length L so that there are L =2
L possible
haplotypes to consider. Let  ρkz , ,  π kz , ,a n d  pkz , be L -
dimensional vectors having j
th components given by the
frequency of haplotypes, in stratum z,a m o n gt h ec a s e s ,
controls, and the entire sample, respectively. Define
the L × L matrix Sk whose (j, j’) element is the sharing
between the j
th and j’
th haplotypes about a fixed locus k.
Here we measure sharing by the maximum information
length contrast [3] metric which counts the number of
single-nucleotide polymorphisms (SNPs) that the j
th and
j’
th haplotypes share identically by state in a window
centered at locus k. To simplify notation we drop the
index k, though it should be understood that all
quantities are computed relative to a given locus k.F o r
each locus, we consider statistics of the form
Uw w zz
T
zz
z
,, γγ ρ π () =− () ∑ S   (1)
where g is a L -dimensional vector that defines the member
of the class and wz is a scalar weight function. Implicit in
these definitions is a “working” model  (h|g)t h e
probability of diplotype h given multilocus genotype g.
This model is used when we compute   ρπ zz − ,a n d  pi ,t h e
distribution of haplotypes consistent with the i
th indivi-
dual’s observed genotype data, under phase ambiguity. It is
not hard to show that (1) can be derived as the efficient
score of a model within the class of models previously
studied by Allen and Satten [4]. As a consequence, they
remain valid even if the “working” model  (h|g)i s
misspecified. Further, it is not necessary to adjust the
variance of our test statistic to account for uncertainty in
haplotype frequencies. We exploit these facts by choosing
computationally fast, though perhaps inconsistent, esti-
mates of  (h|g) secure in the fact that such a choice will
not affect the validity of our testing procedure. Here we
consider two members of the class given by Eq. (1): first,
the “p” statistic in which g
z =  pz , and the “cross” statistic in
which gz =(  ρπ zz − ).
We can interpret the “p” and “cross” statistics as testing
for differences in sharing between cases and controls in
the direction of  pz and   ρπ zz − , respectively. The “p”
statistic has the simple variance estimator,
Vp pw p zz
T
z
z    () ==
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i
ii
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For the “cross” statistic the situation is a bit more complex.
We can show that Uw k (, )   ρπ − is distributed as a mixture
of independent c
2 variates with weights given by the
eigenvalues of ˆ Σz S . We approximate this distribution
using the three-moment approximation of Imhoff [5],
which has the computational advantage of only depending
on the trace of ( ˆ Σz S )
m for m =1 ,2 ,3 .
We applied our proposed haplotype sharing methodology
to the RA data provided in Genetic Analysis Workshop 16
Problem 1. This data set has been described elsewhere but,
in brief, contains genotypes that include over 545,000
unique SNPs for 868 patients with RA and 1194 controls.
Genotypes, haplotypes, and quality control
Following Fellay et al. [6], we excluded data from SNPs
that had extensive missingness (missingness >10), devia-
tions from Hardy-Weinberg equilibrium (p-value < 0.001
in controls), and low minor allele frequency (<0.2%). After
this quality control (QC) filtering, 530,817 SNPs remained.
Using the software package PLINK [7], we confirmed that
all pairs of individuals shared less than 12.5% of SNP
alleles (the threshold used by Fellay et al.) identically by
descent. Thus, no individuals were excluded for cryptic
relatedness. No individuals were excluded for missingness.
We used a computationally efficient estimator of the
distribution of haplotypes given the observed genotype
data  (h|g). The phasing program ent [8] was used to
impute a single diplotype for each chromosome of each
study participant. For a given window, the empirical
distribution of the imputed haplotypes composed of SNPs
in the window was used as a simple haplotype frequency
estimator. Haplotype frequency estimates computed in this
way werethenusedinspecifying the “working” modelfor 
(h|g), assuming Hardy-Weinberg equilibrium. We note that
althoughweimputedindividualhaplotypesasasimpleway
to estimate  (h|g), that when computing  pz ,  π z ,a n d  pi ,
we summed individual contributions over  (h|g), and
therefore, explicitly accounted for phase ambiguity. As
discussed above, misspecification of  (h|g) will not affect
the validity of the haplotype-sharing tests.
Adjustment for confounding due to
population stratification
We used the stratification score of Epstein et al. [1] to
adjust our analyses for confounding due to population
stratification. In Epstein et al. [1], partial least squares (PLS)
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a modified principal-component (PC) approach [6] in
place of PLS. This modified PC approach captures the
large-scale genetic variation in the data by minimizing the
influence of a few high linkage disequilibrium (LD)
regions from dominating the first few PCs. This is
accomplished by excluding SNPs that reside in regions of
known high LD from the PC analysis and then further
pruning the PC SNP set to minimize the LD between the
remaining SNPs [6]. Using the first few PCs, four
individuals (D0009459, D0011466, D0012257, and
D0012446) were found to be significant outliers, suggest-
ing appreciable non-white ancestry. These individuals were
excluded from subsequent analyses and when the PC
analysis was repeated, no further outliers were identified.
The first ten PCs were then used in a logistic model of
disease to estimate each individual’s stratification score–
their predicted probability of being a case given the
genomic information contained in the PCs. Four strata
were then formed based on the quantiles of the stratifica-
tion scores, for use in a stratified haplotype-sharing
analysis. For each locus k, we used the sample size in the
z
th stratum as the weight function wz in Eq. (1).
Genome-wide haplotype sharing analysis
The final analysis data set consisted of 517,843 autosomal
SNP genotypes that passed QC from 868 case participants
Figure 1
Manhattan plot of -log10(p-value)s of haplotype sharing tests for autosomal SNPs passing QC filtering. Solid
horizontal line represents Bonferroni genome-wide threshold. Dashed horizontal line represents genome-wide threshold
estimated via permutation.
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applied two stratified haplotype-sharing tests: the cross
test and the p test. Each test was calculated using a sliding
window of seven SNPs. We measured inflation of test
statistics due to residual population stratification by the
variance inflation factor (VIF), defined as ratio of the
median of the observed and expected chi-square statistics
across the genome. Permutation tests were conducted by
randomly permuting case/control labels within each strata
and then capturing the minimum p-value of each statistic
across the genome for each permutation. We estimated
genome-wide significance by comparing the observed
p-values to this permutation distribution.
Results
We first confirmed the stratification score controlled for
inflation due to population stratification. An unadjusted
single locus analysis [9] showed a VIF of 1.44, suggesting
that significant stratification exist in these data. The
stratified p and cross tests had VIFs of 1.03 and 1.04,
respectively, suggesting minimal residual inflation. The
results of these stratified haplotype sharing analyses
across autosomal SNPs are given in Figure 1.
O u t s i d et h eH L Ar e g i o no nc h r o m o s o m e6 ,t h ep test
shows no further regions associated with RA. However,
the cross test implicated two genomic regions having -
log10(p-value)s that exceed the permutation-based gen-
ome-wide threshold. These regions are: 7q33 (windows
centered at rs6467709, rs6964837, rs834092, rs834082,
rs834067, rs1646366, rs834063, and rs864434), and
13q31.3 (window centered at rs9584093). Each of these
regions contain genes with interesting potential connec-
tions with RA. The region on chromosome 7 is adjacent
to the pleiotrophin gene (PTN), which has been found to
be up-regulated in synovial tissues from patients with RA
[10]. The region on chromosome 7 contains glypican 6
(GPC 6). Glypicans have been shown to be expressed
differentially in chronically inflamed synovium [11].
Conclusion
Apart from the HLA region on chromosome 6, none of
the regions implicated in our analysis were found by a
single-locus GWA analysis that was appropriately cor-
rected for population stratification [9]. This suggests that
haplotype-based methods should have a role in the
analysis of GWAS. The current approach of single-locus
tests, possibly followed by a small-scale application of
haplotype methods in candidate regions or regions
where the single-SNP results are significant or almost
significant may miss regions where a haplotype-based
approach would find a signal. More generally, the
strategy of evaluating haplotype methods by evaluating
their performance in regions implicated by single-
SNP methods may result in the false impression that
single-SNP methods out-perform haplotype-based
methods.
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